<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20937321</PMID><DateCompleted><Year>2011</Year><Month>03</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2518</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>51</Issue><PubDate><Year>2010</Year><Month>Nov</Month><Day>29</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>Passive protection effect of chicken egg yolk immunoglobulins on enterovirus 71 infected mice.</ArticleTitle><Pagination><StartPage>8189</StartPage><EndPage>8196</EndPage><MedlinePgn>8189-96</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2010.09.089</ELocationID><Abstract><AbstractText>The objective of this study is to evaluate the passive protective efficiency of immunoglobulin in yolk (IgY) specific against human enterovirus type 71 (EV71). The antibody was raised by intramuscular immunization to 10 White Leghorn hens, with inactivated human EV71 serving as the antigen. The titer and specificity of the antibody were analyzed from purified IgY in the egg yolks of immunized hens. Results indicate that the titer of IgY specific against EV71 increased from the third week after the first immunization. The content of total IgY was 190 &#xb1; 26 mg/yolk, with an average concentration of specific IgY of 6.34 &#xb1; 3.38 mg/yolk in the eggs from 3 to 18 wk after immunization. The results of the neutralization effect of specific IgY in EV71-challenged mice demonstrate that the EV71-specific IgY, either by intraperitoneal injection or oral administration, was able to significantly reduce the morbidity and mortality in EV71 infected mice pups.</AbstractText><CopyrightInformation>Copyright &#xa9; 2010 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liou</LastName><ForeName>Jenn-Fa</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>National Cheng Kung University, Tainan 701, Taiwan, ROC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Chih-Wei</ForeName><Initials>CW</Initials></Author><Author ValidYN="Y"><LastName>Tailiu</LastName><ForeName>Jui-jane</ForeName><Initials>JJ</Initials></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Chun-Keung</ForeName><Initials>CK</Initials></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Huan-Yao</ForeName><Initials>HY</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lih-Ren</ForeName><Initials>LR</Initials></Author><Author ValidYN="Y"><LastName>Tai</LastName><ForeName>Chein</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>10</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004527">Egg Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C016512">IgY</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007136">Immunoglobulins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002645" MajorTopicYN="N">Chickens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004527" MajorTopicYN="N">Egg Proteins</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007116" MajorTopicYN="N">Immunization, Passive</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007136" MajorTopicYN="N">Immunoglobulins</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007274" MajorTopicYN="N">Injections, Intraperitoneal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008813" MajorTopicYN="N">Mice, Inbred ICR</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2010</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2010</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2010</Year><Month>10</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20937321</ArticleId><ArticleId IdType="pmc">PMC7115624</ArticleId><ArticleId IdType="doi">10.1016/j.vaccine.2010.09.089</ArticleId><ArticleId IdType="pii">S0264-410X(10)01431-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gassmann M., Thommes P., Weiser T., Hubscher U. Efficient production of chicken egg yolk antibodies against a conserved mammalian protein. Faseb J. 1990;4:2528&#x2013;2532.</Citation><ArticleIdList><ArticleId IdType="pubmed">1970792</ArticleId></ArticleIdList></Reference><Reference><Citation>Leslie G.A., Clem L.W. Phylogen of immunoglobulin structure and function. Immunoglobulins of the chicken. J Exp Med. 1969;130:1337&#x2013;1352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2138693</ArticleId><ArticleId IdType="pubmed">5352783</ArticleId></ArticleIdList></Reference><Reference><Citation>Amaral J.A., Tino D.E., Franco M., Carneiro-Sampaio M.M., Carbonare S.B. Anti-enteropathogenic Escherichia coli immunoglobulin Y isolated from eggs laid by immunised Leghorn chickens. Res Vet Sci. 2002;72:229&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pubmed">12076119</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin J.H., Yang M., Nam S.W., Kim J.T., Myung N.H., Bang W.G., Roe I.H. Use of egg yolk-derived immunoglobulin as an alternative to antibiotic treatment for control of Helicobacter pylori infection. Clin Diagn Lab Immunol. 2002;9:1061&#x2013;1066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC120060</ArticleId><ArticleId IdType="pubmed">12204960</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokoyama H., Umeda K., Peralta R.C., Hashi T., Icatlo FCJr, Kuroki M., Ikemori Y., Kodama Y. Oral passive immunization against experimental salmonellosis in mice using chicken egg yolk antibodies specific for Salmonella enteritidis and S. typhimurium. Vaccine. 1998;16:388&#x2013;393.</Citation><ArticleIdList><ArticleId IdType="pubmed">9607060</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatta H., Tsuda K., Akachi S., Kim M., Yamamoto T., Ebina T. Oral passive immunization effect of anti-human rotavirus IgY and its behavior against proteolytic enzymes. Biosci Biotechnol Biochem. 1993;57:1077&#x2013;1081.</Citation><ArticleIdList><ArticleId IdType="pubmed">7764069</ArticleId></ArticleIdList></Reference><Reference><Citation>Leclaire R.D., Hunt R.E., Bavari S. Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination. Infect Immun. 2002;70:2278&#x2013;2281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC127924</ArticleId><ArticleId IdType="pubmed">11953360</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatta H., Tsuda K., Ozeki M., Kim M., Yamamoto T., Otake S., Hirasawa M., Katz J., Childers N.K., Michalek S.M. Passive immunization against dental plaque formation in humans: effect of a mouth rinse containing egg yolk antibodies (IgY) specific to Streptococcus mutans. Caries Res. 1997;31:268&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pubmed">9197932</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.B., Mine Y., Stevenson R.M. Effects of hen egg yolk immunoglobulin in passive protection of rainbow trout against Yersinia ruckeri. J Agric Food Chem. 2000;48:110&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pubmed">10637061</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikemori Y., Ohta M., Umeda K., Icatlo F.C.J.R., kuroki M., Yokoyama H., Kodama Y. Passive protection of neonatal calves against bovine coronavirus-induced diarrhea by administration of egg yolk or colostrum antibody powder. Vet Microbiol. 1997;58:105&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7117124</ArticleId><ArticleId IdType="pubmed">9453122</ArticleId></ArticleIdList></Reference><Reference><Citation>Kweon C.H., Kwon B.J., Woo S.R., Kim J.M., Woo G.H., Son D.H., Hur W., Lee Y.S. Immunoprophylactic effect of chicken egg yolk immunoglobulin (IgY) against porcine epidemic diarrhea virus (PEDV) in piglets. J Vet Med Sci. 2000;62:961&#x2013;964.</Citation><ArticleIdList><ArticleId IdType="pubmed">11039591</ArticleId></ArticleIdList></Reference><Reference><Citation>King AMQ, Brown F, Christian P, Hovi T, Hyypi&#xe4; T, Knowles NJ, Lemon SM, Minor PD, Palmenberg AC, Skern T, Stanway G. Picornaviridae in Virus Taxonomy. Seventh Report of the International Committee for the Taxonomy of Viruses. Academic Press, New-York, San Diego, 2000, pp. 657&#x2013;673.</Citation></Reference><Reference><Citation>Schmidt N.J., Lennette E.H., Ho H.H. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis. 1974;129:304&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiung G.D., Wang J.R. Enterovirus infections with special reference to enterovirus 71. J Microbiol Immunol Infect. 2000;33:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10806956</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M., Chen E.R., Hsu K.H., Twu S.J., Chen K.T., Tsai S.F., Wang J.R., Shih S.R. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med. 1999;341:929&#x2013;935.</Citation><ArticleIdList><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Lum L.C., Wong K.T., Lam S.K., Chua K.B., Goh A.Y., Lim W.L., Ong B.B., Paul G., Abubaker S., Lamber T.M. Fatal enterovirus 71 encephalomyelitis. J Pediatr. 1998;133:795&#x2013;798.</Citation><ArticleIdList><ArticleId IdType="pubmed">9842048</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu H., Shimizu Y., Takeuchi Y., Ishiko H., Takada H. Outbreak of severe neurologic involvement associated with Enterovirus 71 infection. Pediatr Neurol. 1999;20:17&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">10029254</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.M., Lei H.Y., Huang K.J., Wu J.M., Wang J.R., Yu C.K., Su I.J., Liu C.C. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis. 2003;188:564&#x2013;570.</Citation><ArticleIdList><ArticleId IdType="pubmed">12898444</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotbart H.A., Webster A.D. Treatment of potentially life-threatening enterovirus infections with pleconaril. Clin Infect Dis. 2001;32:228&#x2013;235.</Citation><ArticleIdList><ArticleId IdType="pubmed">11170912</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozhon E., Cox S., Buontempo P., O&#x2019;connell J., Slater W., De Martino J., Schwartz J., Miller G., Arnold E., Zhang A. SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating. Antiviral Res. 1993;21:15&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">8391247</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.C., Wu C.N., Shih S.R., Ho M.S. Characterization of a Vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate. Vaccine. 2002;20:2485&#x2013;2493.</Citation><ArticleIdList><ArticleId IdType="pubmed">12057603</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden F.G., Andries K., Janssen P.A. Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection. Antimicrob Agents Chemother. 1992;36:727&#x2013;732.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189373</ArticleId><ArticleId IdType="pubmed">1503435</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozhon E., Cox S., Buontempo P., O&#x2019;Connell J., Slater W., De Martino J., Schwartz J., Miller G., Arnold E., Zhang A. SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating. Antiviral Res. 1993;21:15&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">8391247</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotbart H.A., Webster A.D. Treatment of potentially life-threatening enterovirus infections with pleconaril. Clin Infect Dis. 2001;32:228&#x2013;235.</Citation><ArticleIdList><ArticleId IdType="pubmed">11170912</ArticleId></ArticleIdList></Reference><Reference><Citation>Starlin R., Reed N., Leeman B., Black J., Trulock E., Mundy L.M. Acute flaccid paralysis syndrome associated with echovirus 19, managed with pleconaril and intravenous immunoglobulin. Clin Infect Dis. 2001;33:730&#x2013;732.</Citation><ArticleIdList><ArticleId IdType="pubmed">11477532</ArticleId></ArticleIdList></Reference><Reference><Citation>Pevear D.C., Tull T.M., Seipel M.E., Groarke J.M. Activity of pleconaril against enteroviruses. Antimicrob Agents Chemother. 1999;43:2109&#x2013;2115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC89431</ArticleId><ArticleId IdType="pubmed">10471549</ArticleId></ArticleIdList></Reference><Reference><Citation>Abzug M.J., Keyserling H.L., Lee M.L., Levin M.J., Rotbart H.A. Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin. Clin Infect Dis. 1995;20:1201&#x2013;1206.</Citation><ArticleIdList><ArticleId IdType="pubmed">7620000</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C.C. Neurological complications of enterovirus 71 infection in children: lessons from this Taiwan epidemic. Acta Paediatr Taiwan. 2001;42:5&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11270188</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu C.K., Chen C.C., Chen C.L., Wang J.R., Liu C.C., Yan J.J., Su I.J. Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice. J Biomed Sci. 2000;7:523&#x2013;528.</Citation><ArticleIdList><ArticleId IdType="pubmed">11060501</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan J.J., Su I.J., Chen P.F., Liu C.C., Yu C.K., Wang J.R. Complete genome analysis of enterovirus 71 isolated from an outbreak in Taiwan and rapid identification of enterovirus 71 and coxsackievirus A16 by RT-PCR. J Med Virol. 2001;65:331&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pubmed">11536241</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.F., Chou C.T., Lei H.Y., Liu C.C., Wang S.M., Yan J.J., Su I.J., Wang J.R., Yeh T.M., Chen S.H., Yu C.K. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol. 2004;78:7916&#x2013;7924.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC446098</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>Akita E.M., Nakai S. Comparison of four purification methods for the production of immunoglobulins from eggs laid by hens immunized with an enterotoxigenic E. coli strain. J Immunol Methods. 1993;160:207&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pubmed">8459107</ArticleId></ArticleIdList></Reference><Reference><Citation>Akita E.M., Nakai S. Immunoglobulins from egg yolk: isolation and purification. J Food Science. 1992;57:629&#x2013;634.</Citation></Reference><Reference><Citation>Lee E.N., Sunwoo H.H., Menninen K., Sim J.S. In vitro studies of chicken egg yolk antibody (IgY) against Salmonella enteritidis and Salmonella typhimurium. Poult Sci. 2002;81:632&#x2013;641.</Citation><ArticleIdList><ArticleId IdType="pubmed">12033412</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu C.K., Chen C.C., Chen C.L., Wang J.R., Liu C.C., Yan J.J., Su I.J. Neutralizing antibody provided protection against enterovirus type 71 lethal challenge in neonatal mice. J Biomed Sci. 2000;7:523&#x2013;528.</Citation><ArticleIdList><ArticleId IdType="pubmed">11060501</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarker S.A., Casswall T.H., Juneja L.R., Hoq E., Hossain I., Fuchs G.J., Hammarstrom L. Randomized, placebo-controlled, clinical trial of hyperimmunized chicken egg yolk immunoglobulin in children with rotavirus diarrhea. J Pediatr Gastroenterol Nutr. 2001;32:19&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">11176319</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith D.J., King W.F., Godiska R. Passive transfer of immunoglobulin Yantibody to Streptococcus mutans glucan binding protein B can confer protection against experimental dental caries. Infect Immun. 2001;69:3135&#x2013;3142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC98269</ArticleId><ArticleId IdType="pubmed">11292733</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander J.P.J.R., Baden L., Pallansch M.A., Anderson L.J. Enterovirus 71 infections and neurologic disease-United States, 1977&#x2013;1991. J Infect Dis. 1994;169:905&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pubmed">8133108</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuda G.M., Chang W.K., Yeung C.Y., Tang P.S. Monoplegia caused by enterovirus 71: an outbreak in Hong Kong. Pediatr Infect Dis J. 1987;6:206&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">3562141</ArticleId></ArticleIdList></Reference><Reference><Citation>Melnick J.L. Enterovirus type 71 infections: a varied clinical pattern sometimes mimicking paralytic poliomyelitis. Rev Infect Dis. 1984;6(Suppl 2):S387&#x2013;390.</Citation><ArticleIdList><ArticleId IdType="pubmed">6330839</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.M., Liu C.C., Tseng H.W., Wang J.R., Huang C.C., Chen Y.J., Yang Y.J., Lin S.J., Yeh T.F. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis. 1999;29:184&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">10433583</ArticleId></ArticleIdList></Reference><Reference><Citation>Sungino H., Nitoda T., Juneja L.R. General chemical composition of hen eggs. In: Yammamoti T., Juneja L.R., Hatta H., Kim M., editors. Hen eggs:Their basic and applied science. CRC Press; 1997.</Citation></Reference><Reference><Citation>Reuveny S., White M.D., Adar Y.Y., Kafri Y., Altboum Z., Gozes Y., Kobiler D., Shafferman A., Velan B. Search for correlates of protective immunity conferred by anthrax vaccine. Infect Immun. 2001;69:2888&#x2013;2893.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC98239</ArticleId><ArticleId IdType="pubmed">11292703</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss S., Kobiler D., Levy H., Marcus H., Pass A., Rothschild N., Altboum Z. Immunological correlates for protection against intranasal challenge of Bacillus anthracis spores conferred by a protective antigen-based vaccine in rabbits. Infect Immun. 2006;74:394&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1346658</ArticleId><ArticleId IdType="pubmed">16368995</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovacs N.J., Yoo D., Mine Y. Fine mapping of sequential neutralization epitopes on the subunit protein VP8 of human rotavirus. Biochem J. 2003;376:269&#x2013;275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1223744</ArticleId><ArticleId IdType="pubmed">12901721</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y., Zhou Y., Wu H., Luo B., Chen J., Li W., Jiang S. Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines. J Immunol. 2004;173:4050&#x2013;4057.</Citation><ArticleIdList><ArticleId IdType="pubmed">15356154</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayward J.C., Gillespie S.M., Kaplan K.M., Packer R., Pallansch M., Plotkin S., Schonberger L.B. Outbreak of poliomyelitis-like paralysis associated with enterovirus 71. Pediatr Infect Dis J. 1989;8:611&#x2013;616.</Citation><ArticleIdList><ArticleId IdType="pubmed">2797956</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.C., Yu C.K., Wang Y.F., Liu C.C., Su I.J., Lei H.Y. A murine oral enterovirus 71 infection model with central nervous system involvement. J Gen Virol. 2004;85:69&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">14718621</ArticleId></ArticleIdList></Reference><Reference><Citation>Marquardt R.R., Jin L.Z., Kim J.W., Fang L., Frohlich A.A. Passive protective effect of egg-yolk antibodies against enterotoxigenic Escherichia coli K88+ infection in neonatal and early-weaned piglets. FEMS Immunol Med Microbiol. 1999;23:283&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">10225287</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishimaru Y., Nakano S., Yamaoka K., Takami S. Outbreaks of hand, foot and mouth diease by enterovirus 71. High incidence of complication disorders of central nervous system. Arch Dis Child. 1980;55:206&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1627055</ArticleId><ArticleId IdType="pubmed">6254449</ArticleId></ArticleIdList></Reference><Reference><Citation>Yolken R.H., Leister F., Wee S.B., Miskuff R., Vonderfech T.S. Antibodies to rotaviruses in chickens&#x2019; eggs: a potential source of antiviral immunoglobulins suitable for human consumption. Pediatrics. 1988;81:291&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pubmed">2829106</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatta H., Tsuda K., Akachi S., Kim M., Yamamoto T. Productivity and some properties of egg yolk antibody (IgY) against human rotavirus compared withr abbit IgG. Biosci Biotechnol Biochem. 1993;57:450&#x2013;454.</Citation><ArticleIdList><ArticleId IdType="pubmed">7764050</ArticleId></ArticleIdList></Reference><Reference><Citation>Horie K., Horie N., Abdou A.M., Yang J.O., Yun S.S., Chun H.N., Park C.K., Kim M., Hatta H. Suppressive effect of functional drinking yogurt containing specific egg yolk immunoglobulin on Helicobacter pylori in humans. J Dairy Sci. 2004;87:4073&#x2013;4079.</Citation><ArticleIdList><ArticleId IdType="pubmed">15545368</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>